Unusual Machines grants CEO 5M performance warrants
Unusual Machines, Inc. approved new equity incentives for senior executives.
Rhea-AI Filing Summary
Unusual Machines, Inc. approved new equity incentives for senior executives. The Compensation Committee granted warrants to purchase 5,000,000 shares of common stock to CEO Dr. Allan Evans at an exercise price of $25.00 per share, expiring July 24, 2031, subject to shareholder approval.
The CEO warrants vest in five tranches of 1,000,000 shares when the average closing price of the common stock over 20 consecutive trading days reaches $25.00, $40.00, $60.00, $80.00 and $100.00. In connection with this grant, Dr. Evans agreed to waive all cash compensation after December 31, 2026. The Committee also granted five-year stock options at $19.36 per share to President Andrew Camden (525,000 options), CFO Brian Hoff (375,000), and CRO Stacy Wright (375,000), vesting in 12 equal quarterly installments over three years, subject to continued employment.
Positive
- None.
Negative
- None.
8-K Event Classification
Key Figures
Key Terms
exercise price financial
vest in five equal tranches financial
average closing price financial
Compensation Committee financial
stock options financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What equity incentive did Unusual Machines (UMAC) grant its CEO?
What stock price targets trigger vesting of Dr. Allan Evans’ warrants at UMAC?
How does Dr. Allan Evans’ cash compensation change after 2026 at Unusual Machines (UMAC)?
What stock options were granted to other Unusual Machines (UMAC) executives?
What is the vesting schedule for the new UMAC executive stock options?
AI-generated analysis. How Rhea-AI works. Not financial advice.